Needham & Company Maintains a 'Buy' on Biolase Technology (BLTI); The Turnaround Continues; Raising Estimates & Price Target
Tweet Send to a Friend
Needham & Company maintains a 'Buy' on Biolase Technology (NASDAQ: BLTI), PT increased from $5.40 to $7.
Needham analyst says ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Needham analyst says ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
